Amorphous Solid Dispersions for BCS Class II Antihyperlipidemic Drugs: From Drug-Polymer Interactions to in vivo Performance. [PDF]
Ridwan S +3 more
europepmc +1 more source
The Biopharmaceutics Classification System (BCS) has provided a mechanistic framework for understanding the concept of drug absorption in terms of permeability and solubility. Regulatory guidance for Immediate Release (IR) products incorporating the BCS has appeared over recent months.
openaire +1 more source
Bile acids and nanotechnology as emerging platforms for drug delivery. [PDF]
Sen LY +7 more
europepmc +1 more source
Virtual bioequivalence-guided PBBM prediction for ibuprofen/diphenhydramine citrate tablets: impact of dissolution variability and clinical standard development. [PDF]
Wang Z +10 more
europepmc +1 more source
Food-drug interactions of novel drugs used in cardiologic and diabetic patients - a PRISMA scoping review. [PDF]
Pawłowska I +4 more
europepmc +1 more source
The Effect of Food and the Proton Pump Inhibitor Rabeprazole on Binimetinib Pharmacokinetics in Healthy Participants. [PDF]
Hahn E +5 more
europepmc +1 more source
Emerging perspectives on leveraging physiologically based biopharmaceutics modeling (PBBM) for BCS class III biowaivers: A webinar summary. [PDF]
Fang L +8 more
europepmc +1 more source
Kinetic Model for Describing the Spring Effect and Incomplete Dissolution in Low-Solubility Drug Formulations Based on the Quality-by-Design (QbD) Approach. [PDF]
Orosz LI, Fábián I, Kalmár J.
europepmc +1 more source
The Evolving Role of In Vitro-In Vivo Correlation in Model-Informed Drug Development: A Multi-Stakeholder Perspective. [PDF]
Chenel M +7 more
europepmc +1 more source
Investigating the Impact of Food Induced Fluid Viscosity on Disintegration and Dissolution of Immediate Release Midodrine HCl Tablet. [PDF]
Doole FT +10 more
europepmc +1 more source

